We employed our syngeneic SK-N-SH neuroblastoma cell pair expressing exogenous MYCN or GFP [11] and performed untargeted liquid chromatography/tandem mass spectrometry of cell lysates to determine changes in a broad array of polar metabolites. The gene discussed is MYCN; the disease is neuroblastoma.